Exhibit 99.1

Joint Filer Information

Name of Joint Filer:	Knight Therapeutics Inc.
Address of Joint Filer:	3400 de Maisonneuve W. Suite 1055, Montréal, Quebec H3Z 3B8
Relationship of Joint Filer to Issuer:	Indirect Former 10% Beneficial Owner
Issuer Name and Ticker or Trading Symbol:	60 DEGREES PHARMACEUTICAL, INC. [SXTP]
Date of Event Requiring Statement:	July 28, 2023
Designated Filer:	Knight Therapeutics Inc.
Signature:

KNIGHT THERAPEUTICS INC.
By:	/s/ Samira Sakhia
Name: Samira Sakhia
Title: President and Chief Executive Officer
Date: April 3, 2024

Name of Joint Filer:	Knight Therapeutics International S.A.
Address of Joint Filer:	Dr. Luis Bonavita 1294, of. 2004, Montevideo, Uruguay
Relationship of Joint Filer to Issuer:	Direct Former 10% Beneficial Owner
Issuer Name and Ticker or Trading Symbol:	60 DEGREES PHARMACEUTICAL, INC. [SXTP]
Date of Event Requiring Statement:	July 28, 2023
Designated Filer:	Knight Therapeutics Inc.
Signature:

KNIGHT THERAPEUTICS INTERNATIONAL S.A.
By:	/s/ Arvind Utchanah
Name: Arvind Utchanah
Title: President of the Board of Directors
Date: April 3, 2024

2